- Home
- PRLD vs GROV Comparison
PRLD vs GROV Comparison
Compare PRLD & GROV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- GROV
- Stock Information
- Founded
- PRLD 2016
- GROV 2016
- Country
- PRLD United States
- GROV United States
- Employees
- PRLD N/A
- GROV N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- GROV Package Goods/Cosmetics
- Sector
- PRLD Health Care
- GROV Consumer Discretionary
- Exchange
- PRLD Nasdaq
- GROV Nasdaq
- Market Cap
- PRLD 69.1M
- GROV 64.0M
- IPO Year
- PRLD 2020
- GROV N/A
- Fundamental
- Price
- PRLD $1.58
- GROV $1.32
- Analyst Decision
- PRLD Strong Buy
- GROV Buy
- Analyst Count
- PRLD 3
- GROV 2
- Target Price
- PRLD $4.00
- GROV $1.35
- AVG Volume (30 Days)
- PRLD 258.3K
- GROV 90.7K
- Earning Date
- PRLD 10-31-2025
- GROV 11-07-2025
- Dividend Yield
- PRLD N/A
- GROV N/A
- EPS Growth
- PRLD N/A
- GROV N/A
- EPS
- PRLD N/A
- GROV N/A
- Revenue
- PRLD $7,000,000.00
- GROV $185,354,000.00
- Revenue This Year
- PRLD N/A
- GROV N/A
- Revenue Next Year
- PRLD N/A
- GROV $11.10
- P/E Ratio
- PRLD N/A
- GROV N/A
- Revenue Growth
- PRLD N/A
- GROV N/A
- 52 Week Low
- PRLD $0.61
- GROV $1.02
- 52 Week High
- PRLD $1.91
- GROV $1.95
- Technical
- Relative Strength Index (RSI)
- PRLD 57.91
- GROV 37.72
- Support Level
- PRLD $1.49
- GROV $1.23
- Resistance Level
- PRLD $1.72
- GROV $1.50
- Average True Range (ATR)
- PRLD 0.17
- GROV 0.08
- MACD
- PRLD 0.02
- GROV -0.03
- Stochastic Oscillator
- PRLD 75.44
- GROV 26.47
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.